These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38247265)

  • 1. Placebo and Nocebo Responses in Pharmacological Trials of Tic Disorders: A Meta-Analysis.
    Wang S; Xiong Z; Cui Y; Fan F; Zhang S; Jia R; Hu Y; Li L; Zhang X; Han F
    Mov Disord; 2024 Mar; 39(3):585-595. PubMed ID: 38247265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo and nocebo reactions in randomized trials of pharmacological treatments for persistent depressive disorder. A meta-regression analysis.
    Meister R; Jansen A; Härter M; Nestoriuc Y; Kriston L
    J Affect Disord; 2017 Jun; 215():288-298. PubMed ID: 28363152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do randomized clinical trials with inadequate blinding report enhanced placebo effects for intervention groups and nocebo effects for placebo groups?
    Feys F; Bekkering GE; Singh K; Devroey D
    Syst Rev; 2014 Feb; 3():14. PubMed ID: 24555576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo and nocebo responses in restless legs syndrome: A systematic review and meta-analysis.
    Silva MA; Duarte GS; Camara R; Rodrigues FB; Fernandes RM; Abreu D; Mestre T; Costa J; Trenkwalder C; Ferreira JJ
    Neurology; 2017 Jun; 88(23):2216-2224. PubMed ID: 28490647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nocebo response in Parkinson's disease: A systematic review and meta-analysis.
    Leal Rato M; Duarte GS; Ferreira AN; Alves M; Mainoli B; Teodoro T; Mestre TA; Costa J; Ferreira JJ
    Parkinsonism Relat Disord; 2019 Aug; 65():13-19. PubMed ID: 31103487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo and nocebo responses in other movement disorders besides Parkinson's disease: How much do we know?
    Ferreira JJ; Trenkwalder C; Mestre TA
    Mov Disord; 2018 Aug; 33(8):1228-1235. PubMed ID: 30230626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nocebo effect in myasthenia gravis: systematic review and meta-analysis of placebo-controlled clinical trials.
    Varma A; Zis P
    Acta Neurol Belg; 2019 Jun; 119(2):257-264. PubMed ID: 31004288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of placebo-arm dropouts in osteoporosis randomized-controlled trials and implications for nocebo-associated discontinuation of anti-osteoporotic drugs in clinical practice.
    Kravvariti E; Kasdagli MI; Diomatari KM; Mouratidou P; Daskalakis K; Mitsikostas DD; Sfikakis PP; Yavropoulou MP
    Osteoporos Int; 2023 Mar; 34(3):585-598. PubMed ID: 36596944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo and nocebo responses in randomised, controlled trials of medications for ADHD: a systematic review and meta-analysis.
    Faraone SV; Newcorn JH; Cipriani A; Brandeis D; Kaiser A; Hohmann S; Haege A; Cortese S
    Mol Psychiatry; 2022 Jan; 27(1):212-219. PubMed ID: 33972692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo and nocebo responses in randomized controlled trials of Janus kinase inhibitor monotherapy for rheumatoid arthritis : A meta-analysis.
    Sung YK; Lee YH
    Z Rheumatol; 2022 Jun; 81(5):430-437. PubMed ID: 33687525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse events in trials of licensed drugs for irritable bowel syndrome with constipation or diarrhea: Systematic review and meta-analysis.
    Barberio B; Savarino EV; Black CJ; Ford AC
    Neurogastroenterol Motil; 2022 Jun; 34(6):e14279. PubMed ID: 34672052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining the Nocebo Effect in Trials of Neuromodulators for Use in Disorders of Gut-Brain Interaction.
    Glissen Brown JR; Sanayei A; Proctor S; Flanagan R; Ballou S; Bain PA; Nee J
    Am J Gastroenterol; 2023 Apr; 118(4):692-701. PubMed ID: 36563308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of the Placebo and Nocebo effects associated with Placebo treatment in randomized trials of lipid-lowering therapies.
    Chin YH; Lim O; Lin C; Chan YY; Kong G; Ng CH; Chong B; Syn N; Chan KE; Muthiah MD; Siddiqui MS; Wang JW; Figtree G; Chan MY; Chew NWS
    Eur Heart J Qual Care Clin Outcomes; 2023 Aug; 9(5):511-519. PubMed ID: 36107462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nocebo Response in the Pharmacological Management of Overactive Bladder: A Systematic Review and Meta-analysis.
    Mostafaei H; Mori K; Quhal F; Miura N; Motlagh RS; Pradere B; Laukhtina E; Lysenko I; Ghaffari S; Hajebrahimi S; Shariat SF
    Eur Urol Focus; 2021 Sep; 7(5):1143-1156. PubMed ID: 33153953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placebo and nocebo responses in painful diabetic neuropathy: systematic review and meta-analysis.
    Frisaldi E; Vollert J; Al Sultani H; Benedetti F; Shaibani A
    Pain; 2024 Jan; 165(1):29-43. PubMed ID: 37530658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nocebo Responses in Brain Diseases: A Systematic Review of the Current Literature.
    Zis P; Mitsikostas DD
    Int Rev Neurobiol; 2018; 139():443-462. PubMed ID: 30146057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nocebo effect in multiple system atrophy: systematic review and meta-analysis of placebo-controlled clinical trials.
    Wang ZX; Zhang NN; Zhao HX; Song J
    Neurol Sci; 2022 Feb; 43(2):899-905. PubMed ID: 34973075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nocebo in Alzheimer's disease; meta-analysis of placebo-controlled clinical trials.
    Zis P; Mitsikostas DD
    J Neurol Sci; 2015 Aug; 355(1-2):94-100. PubMed ID: 26073486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placebo and nocebo responses in drug trials of epilepsy.
    Zaccara G; Giovannelli F; Schmidt D
    Epilepsy Behav; 2015 Feb; 43():128-34. PubMed ID: 25703333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.